Cutting PSA Screening Could Triple Metastatic Prostate Cancer Cases, University of Rochester Medical Center Reveals

Prostate cancer is the second leading cause of cancer death in the male population. Screening for the disease is done through a PSA test, but professional organizations vary in their recommendations about who should — and who shouldn't — get it. Now a new analysis on this controversial test it saying you should! The new analysis has found that doing away with PSA (prostate specific antigen) testing for prostate cancer would likely cause three times as many men to develop advanced disease that has spread to other parts of the body before being diagnosed.